Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when explaining or planning around ACM CCS peer review, the two-cycle HotCRP workflow, decision categories including minor revision, the rebuttal window, the adversarial reviewer pool, ethics and disclosure scrutiny, meta-review dynamics, and ACM proceedings outcomes.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
Use this to reason about review-stage strategy. Reopen the current CFP, the cycle's HotCRP site, the reviewer guidelines if posted, and the ethics policy before making process claims.
| Review dimension | What raises it | What sinks it |
|---|---|---|
| Threat model | A tight, realistic adversary stated up front | Capabilities that quietly grow to make the attack work |
| Novelty | An attack class or guarantee the literature lacked | An increment over a cited paper with no new idea |
| Evidence | End-to-end demonstration against a real target | Lab-only results against a strawman |
| Ethics | Disclosure done, harm minimized, reasoned in the paper | Real-world harm with no disclosure or IRB reasoning |
[Current stage] submitted / reviews / rebuttal / decision / revision / camera-ready
[Decision actors] <reviewers / ethics reviewer / meta-reviewer / chairs>
[Likely leverage] <threat model / novelty / evidence / ethics>
[Forbidden moves] <identity leak / new unsupported results / ignoring the shepherd>
[Next response move] <one action>
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。